IRIS Accounts Production v25.1.0.734 04653076 Board of Directors 1.9.23 31.8.24 31.8.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh046530762023-08-31046530762024-08-31046530762023-09-012024-08-31046530762022-08-31046530762022-09-012023-08-31046530762023-08-3104653076ns15:EnglandWales2023-09-012024-08-3104653076ns14:PoundSterling2023-09-012024-08-3104653076ns10:Director12023-09-012024-08-3104653076ns10:PrivateLimitedCompanyLtd2023-09-012024-08-3104653076ns10:SmallEntities2023-09-012024-08-3104653076ns10:AuditExempt-NoAccountantsReport2023-09-012024-08-3104653076ns10:SmallCompaniesRegimeForDirectorsReport2023-09-012024-08-3104653076ns10:SmallCompaniesRegimeForAccounts2023-09-012024-08-3104653076ns10:FullAccounts2023-09-012024-08-3104653076ns5:CurrentFinancialInstruments2024-08-3104653076ns5:CurrentFinancialInstruments2023-08-3104653076ns5:ShareCapital2024-08-3104653076ns5:ShareCapital2023-08-3104653076ns5:RetainedEarningsAccumulatedLosses2024-08-3104653076ns5:RetainedEarningsAccumulatedLosses2023-08-3104653076ns10:RegisteredOffice2023-09-012024-08-3104653076ns5:OwnedOrFreeholdAssetsns5:LandBuildings2023-09-012024-08-3104653076ns5:FurnitureFittings2023-09-012024-08-3104653076ns5:MotorVehicles2023-09-012024-08-3104653076ns5:LandBuildings2023-08-3104653076ns5:FurnitureFittings2023-08-3104653076ns5:MotorVehicles2023-08-3104653076ns5:ComputerEquipment2023-08-3104653076ns5:LandBuildings2023-09-012024-08-3104653076ns5:ComputerEquipment2023-09-012024-08-3104653076ns5:LandBuildings2024-08-3104653076ns5:FurnitureFittings2024-08-3104653076ns5:MotorVehicles2024-08-3104653076ns5:ComputerEquipment2024-08-3104653076ns5:LandBuildings2023-08-3104653076ns5:FurnitureFittings2023-08-3104653076ns5:MotorVehicles2023-08-3104653076ns5:ComputerEquipment2023-08-3104653076ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-08-3104653076ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-08-310465307612023-09-012024-08-31
REGISTERED NUMBER: 04653076 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 AUGUST 2024

FOR

MULBERRY MEDICAL LIMITED

MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024










Page

Statement of Financial Position 1 to 2

Notes to the Financial Statements 3 to 7


MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

STATEMENT OF FINANCIAL POSITION
31 AUGUST 2024

31.8.24 31.8.23
Notes £    £   
FIXED ASSETS
Tangible assets 4 104,292 124,432

CURRENT ASSETS
Stocks 17,500 15,000
Debtors 5 463,118 251,962
Cash at bank 70,545 85,526
551,163 352,488
CREDITORS
Amounts falling due within one year 6 (142,335 ) (131,933 )
NET CURRENT ASSETS 408,828 220,555
TOTAL ASSETS LESS CURRENT
LIABILITIES

513,120

344,987

PROVISIONS FOR LIABILITIES (22,104 ) (21,389 )
NET ASSETS 491,016 323,598

CAPITAL AND RESERVES
Called up share capital 500 500
Retained earnings 490,516 323,098
491,016 323,598

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

STATEMENT OF FINANCIAL POSITION - continued
31 AUGUST 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 January 2025 and were signed on its behalf by:





J Tanqueray - Director


MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024


1. STATUTORY INFORMATION

MULBERRY MEDICAL LIMITED is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 04653076

Registered office: Mulberry House
The Green
Hardingstone
Northampton
Northamptonshire
NN4 7BU

The principal activity of the company in the year under review was that of the provision of medical services.

2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling, which is the functional currency of the entity

JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

REVENUE RECOGNITION
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024


2. ACCOUNTING POLICIES - continued

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 10% on cost
Fixtures and fittings - 25% reducing balance
Motor vehicles - 25% reducing balance

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

STOCKS
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024


2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

Debt instruments are subsequently measured at amortised cost.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately.

For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

CORPORATION TAX
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.

Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.


MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024


2. ACCOUNTING POLICIES - continued
DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

DEFINED CONTRIBUTION PLANS
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.

When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

IMPAIRMENT OF FIXED ASSETS
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cashgenerating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

MULBERRY MEDICAL LIMITED (REGISTERED NUMBER: 04653076)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 AUGUST 2024


4. TANGIBLE FIXED ASSETS
Fixtures
Freehold and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 September 2023 56,287 225,560 140,663 - 422,510
Additions - - 8,490 1,431 9,921
At 31 August 2024 56,287 225,560 149,153 1,431 432,431
DEPRECIATION
At 1 September 2023 26,967 193,924 77,187 - 298,078
Charge for year 5,629 7,909 16,046 477 30,061
At 31 August 2024 32,596 201,833 93,233 477 328,139
NET BOOK VALUE
At 31 August 2024 23,691 23,727 55,920 954 104,292
At 31 August 2023 29,320 31,636 63,476 - 124,432

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade debtors 22,296 15,940
Provision for doubtful debts (4,080 ) (4,080 )
Amounts owed by group undertakings 440,102 240,102
Other debtors 4,800 -
463,118 251,962

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.8.24 31.8.23
£    £   
Trade creditors 26,601 17,923
Tax 60,680 80,132
Social security and other taxes - 357
Other creditors 31,217 20,037
Directors' loan accounts 15,463 8,625
Accruals and deferred income 8,374 4,859
142,335 131,933

7. EVENTS AFTER THE END OF THE REPORTING PERIOD

There were no material events up to the date of approval of the financial statements by the Board.

8. CONTROLLING PARTY

The parent company is Tanqueray Limited, a company registered in England and Wales.